Latest Pneumococcal polysaccharide vaccine Stories
- Latest U.S.
The use of 4 different 13-valent pneumococcal conjugate vaccine immunization schedules in healthy term infants resulted in no statistically significant differences in antibody levels between the infants after the booster dose at 12 months of age for almost all serotypes.
Children who receive a vaccine to prevent blood and ear infections, appear to be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults.
Scientists recently revealed that they plan to study the pneumococcal vaccines in older adults to determine if there’s a strong immune response due to a higher dosage of the vaccine.
The vaccine given to children to immunize against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.
- a meat pie that is usually eaten at Christmas in Quebec